GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savior Lifetec Corp (ROCO:4167) » Definitions » EV-to-FCF

Savior Lifetec (ROCO:4167) EV-to-FCF : 10.72 (As of Apr. 03, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Savior Lifetec EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Savior Lifetec's Enterprise Value is NT$4,288 Mil. Savior Lifetec's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was NT$400 Mil. Therefore, Savior Lifetec's EV-to-FCF for today is 10.72.

The historical rank and industry rank for Savior Lifetec's EV-to-FCF or its related term are showing as below:

ROCO:4167' s EV-to-FCF Range Over the Past 10 Years
Min: -253.36   Med: -9.98   Max: 1858.25
Current: 11.2

During the past 13 years, the highest EV-to-FCF of Savior Lifetec was 1858.25. The lowest was -253.36. And the median was -9.98.

ROCO:4167's EV-to-FCF is ranked worse than
59.96% of 447 companies
in the Biotechnology industry
Industry Median: 2.69 vs ROCO:4167: 11.20

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-03), Savior Lifetec's stock price is NT$19.60. Savior Lifetec's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.560. Therefore, Savior Lifetec's PE Ratio (TTM) for today is 35.00.


Savior Lifetec EV-to-FCF Historical Data

The historical data trend for Savior Lifetec's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savior Lifetec EV-to-FCF Chart

Savior Lifetec Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -84.37 -24.62 12.85 16.38 11.36

Savior Lifetec Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.38 11.06 14.74 13.51 11.36

Competitive Comparison of Savior Lifetec's EV-to-FCF

For the Biotechnology subindustry, Savior Lifetec's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Savior Lifetec's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Savior Lifetec's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Savior Lifetec's EV-to-FCF falls into.


;
;

Savior Lifetec EV-to-FCF Calculation

Savior Lifetec's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4287.686/399.922
=10.72

Savior Lifetec's current Enterprise Value is NT$4,288 Mil.
Savior Lifetec's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$400 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Savior Lifetec  (ROCO:4167) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Savior Lifetec's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=19.60/0.560
=35.00

Savior Lifetec's share price for today is NT$19.60.
Savior Lifetec's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.560.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Savior Lifetec EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Savior Lifetec's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Savior Lifetec Business Description

Traded in Other Exchanges
N/A
Address
No. 29, Kezhong Road, Hsinchu Science Park, Zhunan Township, Miaoli, TWN, 350
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions such as the Americas, Asia, Taiwan, and Europe.

Savior Lifetec Headlines

No Headlines